Vir Biotechnology (VIR) Insider Trading & Ownership $5.88 +0.04 (+0.60%) As of 01:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vir Biotechnology (NASDAQ:VIR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage16.00%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$1.11M Get VIR Insider Trade Alerts Want to know when executives and insiders are buying or selling Vir Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VIR Insider Buying and Selling by Quarter Vir Biotechnology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/17/2025Mark EisnerEVPSell3,586$5.47$19,615.42 7/15/2025Mark EisnerEVPSell6,796$5.47$37,174.12 7/1/2025Vicki L SatoDirectorSell22,000$5.10$112,200.00 6/2/2025Janet NapolitanoDirectorSell3,200$5.05$16,160.00 4/3/2025Backer Marianne DeCEOSell79,712$5.95$474,286.40 2/26/2025Verneuil Vanina DeEVPSell7,373$9.14$67,389.22 2/18/2025George A ScangosDirectorSell10,964$9.81$107,556.84 2/13/2025Brent SabatiniCAOSell1,562$9.15$14,292.30 1/8/2025Vicki L SatoDirectorSell10,960$12.52$137,219.20 12/2/2024Verneuil Vanina DeEVPSell76$8.22$624.72 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/5/2024Verneuil Vanina DeEVPSell2,347$9.47$22,226.09 11/1/2024Verneuil Vanina DeEVPSell1,403$7.20$10,101.60 9/9/2024Janet NapolitanoDirectorSell12,190$7.80$95,082.00 (Data available from 1/1/2013 forward) VIR Insider Trading Activity - Frequently Asked Questions Who is on Vir Biotechnology's Insider Roster? The list of insiders at Vir Biotechnology includes Ann M Hanly, Backer Marianne De, Brent Sabatini, Charles Elliott Sigal, Endurance (Cayman) Ltd Svf, George A Scangos, Howard Horn, Janet Napolitano, Johanna Friedl-Naderer, Mark Eisner, Phillip Pang, Saira Ramasastry, Steven J Rice, Sung Lee, Verneuil Vanina De, and Vicki L Sato. Learn more on insiders at VIR. What percentage of Vir Biotechnology stock is owned by insiders? 16.00% of Vir Biotechnology stock is owned by insiders. Learn more on VIR's insider holdings. Which Vir Biotechnology insiders have been selling company stock? The following insiders have sold VIR shares in the last 24 months: Ann M Hanly ($150,820.35), Backer Marianne De ($1,164,819.10), Brent Sabatini ($14,292.30), George A Scangos ($698,622.10), Janet Napolitano ($111,242.00), Mark Eisner ($56,789.54), Phillip Pang ($34,007.04), Saira Ramasastry ($43,800.00), Sung Lee ($59,419.12), Verneuil Vanina De ($100,341.63), and Vicki L Sato ($249,419.20). How much insider selling is happening at Vir Biotechnology? Insiders have sold a total of 319,000 Vir Biotechnology shares in the last 24 months for a total of $2,683,572.38 sold. Vir Biotechnology Key ExecutivesDr. Marianne De Backer M.B.A. (Age 55)M.Sc., Ph.D., CEO & Director Compensation: $4.47MDr. Ann M. Hanly Ph.D. (Age 54)Executive VP & Chief Technology Officer Compensation: $896.07kDr. Jeff Calcagno M.D. (Age 63)Executive VP & Chief Business Officer Compensation: $860.49kDr. Klaus Frueh Ph.D. (Age 64)Co-Founder & Scientific Advisor Compensation: $177.66kDr. Lawrence Corey M.D. (Age 77)Co-Founder & Scientific Advisor Dr. Louis J. Picker M.D.Co-Founder & Scientific AdvisorDr. Jennifer Eileen Towne Ph.D.Executive VP & Chief Scientific OfficerMs. Heather Rowe ArmstrongVice President of Investor RelationsMs. Vanina De Verneuil J.D.Executive VP, General Counsel & Corporate SecretaryMs. Arran AttridgeSenior Vice President of Corporate Communications More Insider Trading Tools from MarketBeat Related Companies KYMR Insider Selling RARE Insider Selling AMRX Insider Selling MIRM Insider Selling CPRX Insider Selling ARWR Insider Selling IBRX Insider Selling OGN Insider Selling APLS Insider Selling XENE Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NASDAQ:VIR) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredElon Musk: “This will transform civilization as we know it.”Robots are no longer science fiction — they’re the next trillion-dollar megatrend. According to Forbes, by ...Weiss Ratings | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vir Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vir Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
